Product
HMPL-453
2 clinical trials
2 indications
Indication
CholangiocarcinomaIndication
Intrahepatic CholangiocarcinomaClinical trial
A Phase 1, Open-label, 4-period, Randomized 6-sequence Study to Evaluate the Effect of Food and Rabeprazole, a Proton Pump Inhibitor, on the Pharmacokinetics of HMPL-453 in Healthy VolunteersStatus: Completed, Estimated PCD: 2023-08-28
Clinical trial
An Open-Label, Single-Arm, Multicenter Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HMPL-453 Tartrate in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusion/RearrangementStatus: Recruiting, Estimated PCD: 2025-06-30